Table 4.
Serum Marker | Iron | TSAT 3 | Ferritin | sTFR 4 | sTFRF Index 5 | Hepcidin |
---|---|---|---|---|---|---|
60 days post-COVID-19 follow-up | ||||||
CRP–ρ 1 | −0.198 * | −0.272 ** | 0.040 | 0.175 | 0.095 | −0.006 |
Procalcitonin–ρ | −0.085 | −0.069 | 0.089 | 0.185 | 0.060 | −0.012 |
IL6–ρ 2 | −0.202 * | −0.161 | 0.067 | 0.272 ** | 0.213 * | −0.065 |
Neopterin–ρ | −0.185 | −0.158 | 0.235 * | 0.242 * | 0.064 | 0.035 |
D-dimer–ρ | −0.248 * | −0.242 * | 0.028 | 0.177 | 0.131 | −0.191 |
360 days post−COVID−19 follow−up | ||||||
CRP–ρ 1 | −0.335 ** | −0.334 ** | 0.055 | 0.092 | 0.049 | 0.035 |
Procalcitonin–ρ | −0.196 * | −0.141 | 0.213 * | 0.192 * | 0.023 | 0.156 |
IL6–ρ 2 | −0.329 ** | −0.321 ** | 0.001 | 0.030 | 0.052 | 0.056 |
Neopterin–ρ | −0.235 * | −0.178 | 0.140 | 0.238 * | 0.097 | 0.111 |
D-dimer–ρ | −0.121 | −0.071 | 0.006 | −0.049 | −0.034 | 0.021 |
1 C-reactive protein; 2 interleukin-6; 3 transferrin saturation, 4 soluble transferrin receptor, 5 soluble transferrin receptor/log serum ferritin; N = 108, ρ = correlation coefficient rho according to Spearman rho calculation, * p < 0.05, ** p < 0.01.